| CD79B |
CD79B, B29, IGB: B-cell antigen receptor complex-associated protein beta-chain p |
PRKCE |
PRKCE, PKCE: Protein kinase C epsilon type |
5.875 |
Evidence |
|
| IL6ST |
IL6ST: Interleukin-6 receptor subunit beta precursor |
MAP2K1 |
MAP2K1, MEK1, PRKMK1: Dual specificity mitogen-activated protein kinase kinase 1 |
5.875 |
Evidence |
|
| IL6ST |
IL6ST: Interleukin-6 receptor subunit beta precursor |
WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
5.875 |
Evidence |
|
| TGFBR1 |
TGFBR1: TGF-beta receptor type-1 precursor |
CNN2 |
CNN2: Calponin-2 |
5.875 |
Evidence |
|
| TGFBR1 |
TGFBR1: TGF-beta receptor type-1 precursor |
MAPK9 |
MAPK9, JNK2, PRKM9: Mitogen-activated protein kinase 9 |
5.875 |
Evidence |
|
| TGFBR1 |
TGFBR1: TGF-beta receptor type-1 precursor |
MAPK8 |
MAPK8, JNK1, PRKM8: Mitogen-activated protein kinase 8 |
5.875 |
Evidence |
|
| ACVR1B |
ACVR1B, ACVRLK4: Activin receptor type-1B precursor |
MAPK9 |
MAPK9, JNK2, PRKM9: Mitogen-activated protein kinase 9 |
5.875 |
Evidence |
|
| ACVR1B |
ACVR1B, ACVRLK4: Activin receptor type-1B precursor |
MAPK8 |
MAPK8, JNK1, PRKM8: Mitogen-activated protein kinase 8 |
5.875 |
Evidence |
|
| CIITA |
CIITA, MHC2TA: MHC class II transactivator |
ACVR1B |
ACVR1B, ACVRLK4: Activin receptor type-1B precursor |
5.875 |
Evidence |
|
| STIP1 |
STIP1: Stress-induced-phosphoprotein 1 |
ACVR1B |
ACVR1B, ACVRLK4: Activin receptor type-1B precursor |
5.875 |
Evidence |
|
| YWHAB |
YWHAB: 14-3-3 protein beta/alpha |
NFATC2 |
NFATC2, NFAT1, NFATP: Nuclear factor of activated T-cells, cytoplasmic 2 |
5.875 |
Evidence |
|
| DUSP1 |
DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 |
AMPH |
AMPH, AMPH1: Amphiphysin |
5.875 |
Evidence |
|
| MAPK1 |
MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 |
IL6ST |
IL6ST: Interleukin-6 receptor subunit beta precursor |
5.875 |
Evidence |
|
| HLA-DMB |
HLA-DMB, DMB, RING7: HLA class II histocompatibility antigen, DM beta chain prec |
NEK6 |
NEK6: Serine/threonine-protein kinase Nek6 |
5.875 |
Evidence |
|
| ERBB3 |
ERBB3, HER3: Receptor tyrosine-protein kinase erbB-3 precursor |
MAP4K1 |
MAP4K1, HPK1: Mitogen-activated protein kinase kinase kinase kinase 1 |
5.875 |
Evidence |
|
| CD247 |
CD247, CD3Z, T3Z, TCRZ: T-cell surface glycoprotein CD3 zeta chain precursor |
PRKCE |
PRKCE, PKCE: Protein kinase C epsilon type |
5.875 |
Evidence |
|
| CD247 |
CD247, CD3Z, T3Z, TCRZ: T-cell surface glycoprotein CD3 zeta chain precursor |
MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
5.875 |
Evidence |
|
| EPOR |
EPOR: Erythropoietin receptor precursor |
MKNK1 |
MKNK1, MNK1: MAP kinase-interacting serine/threonine-protein kinase 1 |
5.875 |
Evidence |
|
| EPOR |
EPOR: Erythropoietin receptor precursor |
RPS6KA2 |
RPS6KA2, RSK3: Ribosomal protein S6 kinase alpha-2 |
5.875 |
Evidence |
|
| PTPN1 |
PTP1B, PTPN1: Tyrosine-protein phosphatase non-receptor type 1 |
DUSP16 |
DUSP16, KIAA1700, MKP7: Dual specificity protein phosphatase 16 |
5.875 |
Evidence |
|
| CD44 |
IPI00305064 |
MKNK1 |
MKNK1, MNK1: MAP kinase-interacting serine/threonine-protein kinase 1 |
5.875 |
Evidence |
|
| CD44 |
IPI00305064 |
RPS6KA2 |
RPS6KA2, RSK3: Ribosomal protein S6 kinase alpha-2 |
5.875 |
Evidence |
|
| NGFR |
NGFR, TNFRSF16: Tumor necrosis factor receptor superfamily member 16 precursor |
MKNK1 |
MKNK1, MNK1: MAP kinase-interacting serine/threonine-protein kinase 1 |
5.875 |
Evidence |
|
| NGFR |
NGFR, TNFRSF16: Tumor necrosis factor receptor superfamily member 16 precursor |
RPS6KA2 |
RPS6KA2, RSK3: Ribosomal protein S6 kinase alpha-2 |
5.875 |
Evidence |
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
SALF |
GTF2A1L, ALF, GTF2A1LF: TFIIA-alpha and beta-like factor |
5.875 |
Evidence |
|